Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report

Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report

IntroductionCases of central diabetes insipidus (CDI) have been reported after COVID-19 infection, with hypophysitis being the most likely cause. COVID-19 vaccines potential adverse effects may mimetize some of these complications.Case ReportWoman 37 years old, with rheumatoid arthritis under adalim...

Full description

Bibliographic Details
Main Authors: Bruno Bouça, Marisa Roldão, Paula Bogalho, Luís Cerqueira, José Silva-Nunes
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
case report
diabetes insipidus
COVID-19
vaccine
mRNA
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.889074/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.889074/full

Similar Items